Rosenberger Brian

CIK 00016957881 companyDEVON, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001695788

Recent Transactions

23 trades

Disposition from Tender
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10−69,559→ 180,000 total
Disposition from Tender
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10−300,000→ 0 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10+120,000→ 300,000 total
Disposition to Issuer
Zynerba Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2023-10-10−90,000→ 0 total
Sale
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-09-13$1.33/sh−6,411→ 249,559 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-09-12+22,200→ 255,970 total
Tax Payment
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-02-08$0.60/sh−5,145→ 233,770 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-02-07+14,926→ 238,915 total
Tax Payment
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-02-01$0.60/sh−4,809→ 223,989 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-01-31+13,950→ 228,798 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-01-24+120,000→ 214,848 total
Sale
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-01-23$0.60/sh−12,663→ 94,848 total
Sale
Zynerba Pharmaceuticals, Inc.
Common Stock
2022-07-19$1.10/sh−4,289→ 107,511 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2022-07-18+14,800→ 111,800 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2022-01-26+60,000→ 97,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-01-26+90,000→ 90,000 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2021-01-21+37,000→ 37,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-01-21+55,000→ 55,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2020-01-30+10,000→ 10,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2020-01-30+48,000→ 48,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2019-01-24+42,287→ 42,287 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-01-11+42,000→ 42,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2017-01-18+37,500→ 37,500 total

Companies

Zynerba Pharmaceuticals, Inc.
VP, Commercial

Recent Filings

Address

C/O ZYNERBA PHARMACEUTICALS, INC. 80 W. LANCASTER AVENUE, SUITE 300

DEVON, PA, 19333

View on SEC.gov